Researchers at DTU have patented a new invention that uses naturally produced substances from bifidobacteria in the gut to help lower the risk of allergies and asthma. Allergies and asthma are ...
India Education Diary on MSN
New clinical trial to compare the effectiveness of IV treatments for severe asthma in children
India, Jan. 24 -- A clinical trial to determine the best intravenous (IV) treatments for children with severe asthma will go ...
WhiteSands Alcohol & Drug Rehab Orlando has published a new educational resource focused on treatment considerations during ...
WhiteSands Alcohol & Drug Rehab Tampa has published a new educational resource exploring the physiological effects of alcohol ...
As of Friday, January 23, Apogee Therapeutics, Inc.’s APGE share price has dipped by 8.67%, which has investors questioning ...
More than 140 U.S. medical organizations are advocating for the passage of a bill that would increase NIH funding for fiscal ...
Early Phase I data showed inhaled londamocitinib reduced airway inflammation in mild asthma with good tolerability. Learn ...
A woman has praised an urgent treatment centre (UTC) after it discovered she had a heart condition. Staff at the Corby UTC in ...
Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase ...
Apogee Therapeutics (APGE) leverages IL-13 pathway optimization to enable less frequent dosing, targeting a leadership shift ...
A new study shows that internet-delivered cognitive behavioral therapy (ICBT) can effectively reduce asthma-related anxiety ...
Proceeds to advance frevecitinib, an inhaled pan-JAK inhibitor with the potential to treat the broad severe asthma population, through Phase 2 studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results